Search
Chris Thompson, CorpWatch investigative reporter, died January 21, 2016, at his home in Berkeley, California. He was a fearless reporter and progressive activist and will be missed sorely by his readers, family and friends. This week, CorpWatch republishes some of his work for us and with us.
Schering-Plough Corp. on Tuesday agreed to pay $435 million and plead guilty to conspiracy to settle a federal investigation into marketing of its drugs for unapproved uses and overcharging Medicaid for certain drugs.
A major drug company is blocking access to a medicine that is cheaply and effectively saving thousands of people from going blind because it wants to launch a more expensive product on the market.
As the World Health Organisation's top man in Thailand, William Aldis knew Thai officials were hosting their US counterparts in the northern city of Chiang Mai to negotiate what to many outsiders might seem an entirely worthy objective: a biÂlateral free-trade deal. But he saw dangers - and decided to make his views public.
Pharmaceutical multinationals, seeking to ramp up profits through cheap drug trials, are increasingly turning to India with its combination of a vast pool of poor, ignorant patients on the one hand and skilled medical personnel and fine research infrastructure on the other.
The existing system of drug patenting and pricing is fundamentally flawed and does not meet health needs, according to report released to health experts last month.